Literature DB >> 27573709

Loss of H3K27 tri-methylation is a diagnostic marker for malignant peripheral nerve sheath tumors and an indicator for an inferior survival.

Arjen Hg Cleven, Ghadah A Al Sannaa, Inge Briaire-de Bruijn, Davis R Ingram, Matt van de Rijn, Brian P Rubin, Maurits W de Vries, Kelsey L Watson, Kelia E Torres, Wei-Lien Wang, Sjoerd G van Duinen, Pancras Cw Hogendoorn, Alexander J Lazar, Judith Vmg Bovée.   

Abstract

Entities:  

Year:  2016        PMID： 27573709     DOI： 10.1038/modpathol.2016.103

Source DB:  PubMed          Journal:  Mod Pathol        ISSN： 0893-3952            Impact factor:   7.842


× No keyword cloud information.
  9 in total

1.  Loss of H3K27 trimethylation is not suitable for distinguishing malignant peripheral nerve sheath tumor from melanoma: a study of 387 cases including mimicking lesions.

Authors:  Sophie Le Guellec; Nicolas Macagno; Valérie Velasco; Laurence Lamant; Marick Lae; Thomas Filleron; Nausicaa Malissen; Elisabeth Cassagnau; Philippe Terrier; Christine Chevreau; Dominique Ranchere-Vince; Jean-Michel Coindre
Journal:  Mod Pathol       Date:  2017-07-28       Impact factor: 7.842

Review 2.  The rare primary bone sarcomas: imaging-pathological correlation.

Authors:  Rupert Berkeley; Vanghelita Andrei; Asif Saifuddin
Journal:  Skeletal Radiol       Date:  2021-01-07       Impact factor: 2.199

Review 3.  Disruption of mammalian SWI/SNF and polycomb complexes in human sarcomas: mechanisms and therapeutic opportunities.

Authors:  Matthew J McBride; Cigall Kadoch
Journal:  J Pathol       Date:  2018-03-06       Impact factor: 7.996

Review 4.  Current Update on the Molecular Biology of Cutaneous Sarcoma: Dermatofibrosarcoma Protuberans.

Authors:  Takeshi Iwasaki; Hidetaka Yamamoto; Yoshinao Oda
Journal:  Curr Treat Options Oncol       Date:  2019-03-14

5.  Histopathologic findings in malignant peripheral nerve sheath tumor predict response to radiotherapy and overall survival.

Authors:  Calixto-Hope G Lucas; Harish N Vasudevan; William C Chen; Stephen T Magill; Steve E Braunstein; Line Jacques; Sonika Dahiya; Fausto J Rodriguez; Andrew E Horvai; Arie Perry; Melike Pekmezci; David R Raleigh
Journal:  Neurooncol Adv       Date:  2020-10-01

Review 6.  Circulating tumor DNA for malignant peripheral nerve sheath tumors in neurofibromatosis type 1.

Authors:  Jordan Jones; Sarah Cain; Jonathan Pesic-Smith; Peter F M Choong; Andrew P Morokoff; Kate J Drummond; Gabriel Dabscheck
Journal:  J Neurooncol       Date:  2021-09-16       Impact factor: 4.130

7.  Whole exome sequencing reveals the maintained polyclonal nature from primary to metastatic malignant peripheral nerve sheath tumor in two patients with NF1.

Authors:  Abigail Godec; Reyka Jayasinghe; John S A Chrisinger; Bethany Prudner; Tyler Ball; Yuxi Wang; Divya Srihari; Madhurima Kaushal; Hilary Dietz; Xiaochun Zhang; Melike Pekmezci; Sonika Dahiya; Yu Tao; Jinqin Luo; Brian A Van Tine; Li Ding; David H Gutmann; Angela C Hirbe
Journal:  Neurooncol Adv       Date:  2019-09-10

8.  Efficacy of MEK inhibition in a recurrent malignant peripheral nerve sheath tumor.

Authors:  Sumanth Nagabushan; Loretta M S Lau; Paulette Barahona; Marie Wong; Alexandra Sherstyuk; Glenn M Marshall; Vanessa Tyrrell; Eva A Wegner; Paul G Ekert; Mark J Cowley; Chelsea Mayoh; Toby N Trahair; Philip Crowe; Antoinette Anazodo; David S Ziegler
Journal:  NPJ Precis Oncol       Date:  2021-02-12

9.  Enhancer reprogramming in PRC2-deficient malignant peripheral nerve sheath tumors induces a targetable de-differentiated state.

Authors:  Veena Kochat; Ayush T Raman; Sharon M Landers; Ming Tang; Jonathan Schulz; Christopher Terranova; Jace P Landry; Angela D Bhalla; Hannah C Beird; Chia-Chin Wu; Yingda Jiang; Xizeng Mao; Rossana Lazcano; Swati Gite; Davis R Ingram; Min Yi; Jianhua Zhang; Emily Z Keung; Christopher P Scally; Christina L Roland; Kelly K Hunt; Barry W Feig; P Andrew Futreal; Patrick Hwu; Wei-Lien Wang; Alexander J Lazar; John M Slopis; Heather Wilson-Robles; Dominique J Wiener; Ian E McCutcheon; Brandan Wustefeld-Janssens; Kunal Rai; Keila E Torres
Journal:  Acta Neuropathol       Date:  2021-07-20       Impact factor: 17.088
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.